Clinical Trials Browser

Completed × Carcinoma, Transitional Cell × ascrinvacumab × Clear all

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Camurati-Engelmann Syndrome, Neoplasm Metastasis, Recurrence